Upstream Process Protocol for MSCs Isolated from Different Human-Based Tissue Origins

Area of Science:

• Cell biology
• Regenerative medicine
• Biotechnology

Background:

• Mesenchymal stromal/stem cells (MSCs) are increasingly significant in regenerative medicine and cellular therapeutics.
• Growing interest in MSCs for diverse medical applications, including advanced therapy medicinal products (ATMPs).
• Advancements in cell culture technologies enable large-scale MSC production under Good Manufacturing Practices (GMP), ensuring safety and efficacy.

Purpose of the Study:

• To introduce the increasing significance of MSC production.
• To outline the growing interest in MSCs for various medical applications.
• To describe an optimized upstream protocol for laboratory-scale MSC production.

Main Methods:

• Development of an optimized upstream protocol for laboratory-scale MSC production.
• Utilizing different tissue sources for MSC isolation.
• Conducting cell culture in flasks with control of critical parameters.
• Laying the foundation for downstream processing for ATMP generation.

Main Results:

• An optimized laboratory-scale protocol for MSC production was described.
• The protocol controls critical parameters for consistent MSC generation.
• The described method provides a foundation for downstream processing to generate ATMPs.

Conclusions:

• MSC production holds significant potential for clinical applications in regenerative medicine.
• Tailored production processes are essential for generating safe and effective ATMPs.
• The optimized protocol facilitates laboratory-scale MSC production, supporting future therapeutic development.